Regenxbio (RGNX) Capital Expenditures Growth (5y) (2020 - 2025)
Regenxbio (RGNX) Capital Expenditures Growth (5y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Regenxbio |
325.94 Mn |
95.87 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-15.30% |
| Sep 30, 2025 |
15.58% |
| Jun 30, 2025 |
-34.64% |
| Mar 31, 2025 |
-26.05% |
| Dec 31, 2024 |
16.20% |
| Sep 30, 2024 |
-34.38% |
| Jun 30, 2024 |
-38.88% |
| Mar 31, 2024 |
-25.67% |
| Dec 31, 2023 |
-25.45% |
| Sep 30, 2023 |
-15.66% |
| Jun 30, 2023 |
-0.73% |
| Mar 31, 2023 |
15.50% |
| Dec 31, 2022 |
21.09% |
| Sep 30, 2022 |
62.19% |
| Jun 30, 2022 |
40.62% |
| Mar 31, 2022 |
30.22% |
| Dec 31, 2021 |
26.93% |
| Sep 30, 2021 |
46.46% |
| Jun 30, 2021 |
107.40% |
| Mar 31, 2021 |
136.19% |
